ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

2 links0 made here, not in the record7 judgments2 judges (the rules as one: Rule based)2 record changes seen1 read an older version
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05715281Testing the Combination ofAnti-cancer DrugsAtezolizumab andTiragolumab in People WithAdvanced Stage RareCancers, RARE3 TrialNational Cancer Institute (NCIPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Nov 4 · ClinicalTrials.gov record · Version of 2026-11-04Nov 4 · Rule based · Reading set asideNov 10 · Rule based · Read againRead againDRUGSAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTiragolumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 10 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Atezolizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Atezolizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Nov 3AtezolizumabClaude Opus 5.5BackgroundRead an older version
Nov 3TiragolumabClaude Opus 5.5TestedReplaced
Nov 4The record itselfClinicalTrials.gov recordVersion of 2026-11-04Record change
Nov 4The record itselfRule based · nightly checkReading set asideCurrent
Nov 10The record itselfRule based · nightly checkRead againCurrent
Nov 10TiragolumabClaude Opus 5.5TestedCurrent
Nov 18AtezolizumabRule based · role ruleBackgroundCurrent
Nov 18TiragolumabRule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

When a study changes after it was read

Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.

Until it is read again, the page shows the last reading and says so.